These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2245764)

  • 1. [Hyperprolactinemia in malignant lymphomas].
    Grobe N; Rühle H; Eckelmann G
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1825-7. PubMed ID: 2245764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].
    Aulbert E; Steffens O
    Med Klin (Munich); 1990 Jan; 85(1):13-7. PubMed ID: 2179698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The importance of the radioimmunological determination of tumor markers in the diagnosis of malignant lymphomas].
    Purizhanskiĭ II; Pavlichuk SN; Toritsina LK
    Med Radiol (Mosk); 1989 Nov; 34(11):48-51. PubMed ID: 2685505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperprolactinemia in systemic lupus erythematosus. A prospective study of 38 cases].
    Smiti Khanfir M; Ben Ghorbel I; Feki M; Lamloum M; Mebazaa A; Miled M; Houman MH
    Tunis Med; 2004 Jun; 82(6):512-5. PubMed ID: 15517949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ORL manifestations in malignant hemopathies].
    Koffi-Aka V; Akon JC; Koné M; Yotio A; Ehouo F
    Rev Laryngol Otol Rhinol (Bord); 1999; 120(2):97-101. PubMed ID: 10444982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoembryonal antigen (CEA) in malignant lymphomas].
    Kovcin V; Jelić S; Babović N
    Srp Arh Celok Lek; 1994; 122(5-6):168-70. PubMed ID: 17977419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
    Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
    Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of hyperprolactinemia: determination of prolactin level at rest].
    Ishay A; Luboshitzky R
    Harefuah; 1998 Nov; 135(9):348-50, 408, 407. PubMed ID: 10911442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin serum level in patients with breast cancer.
    Cohen AD; Cohen Y; Maislos M; Buskila D
    Isr Med Assoc J; 2000 Apr; 2(4):287-9. PubMed ID: 10804904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
    Lei KI; Johnson PJ
    Cancer; 2000 Sep; 89(6):1387-95. PubMed ID: 11002235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of various clinical and hematological features of various types of non-Hodgkin lymphomas of a low degree of malignancy in relation to age groups].
    Dwilewicz-Trojaczek J; Paprocka E; Rokicka M
    Pol Tyg Lek; 1985 May; 40(20):569-72. PubMed ID: 3839580
    [No Abstract]   [Full Text] [Related]  

  • 17. Verapamil stimulation test in hyperprolactinemia: loss of prolactin response in anatomic or functional stalk effect.
    Dagdelen S; Usman A
    Minerva Endocrinol; 2010 Jun; 35(2):53-9. PubMed ID: 20595935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of proangiogenic cytokines in children with lymphomas.
    Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
    Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity.
    Shahin AA; Abdoh S; Abdelrazik M
    Z Rheumatol; 2002 Dec; 61(6):703-9. PubMed ID: 12491136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.